Biotricity is trading 10.17% down at $0.05; no clear company-specific announcement explaining the November 3, 2026 decline surfaced in the news search. - A trending result about its Bioflux device dates to 2018, not new news. - The supplied market snapshot is mixed and does not establish a broader-market explanation. - Reported volume was 6.16K shares, below the cited 87.34K daily average.